Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 study
- DOI
- 10.1093/oncolo/oyae369
- Published
- 2025-02
- Container
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyae369,
title = {Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 study},
author = {Miguel Zugman and David F McDermott and Bernard J Escudier and Thomas E Hutson and Camillo Porta and Elena Verzoni and Michael B Atkins and Brian Rini and Sumanta K Pal},
year = {2025},
journal = {The Oncologist},
doi = {10.1093/oncolo/oyae369},
url = {https://doi.org/10.1093/oncolo/oyae369}
}RIS
TY - JOUR TI - Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 study AU - Miguel Zugman AU - David F McDermott AU - Bernard J Escudier AU - Thomas E Hutson AU - Camillo Porta AU - Elena Verzoni AU - Michael B Atkins AU - Brian Rini AU - Sumanta K Pal PY - 2025 JO - The Oncologist DO - 10.1093/oncolo/oyae369 UR - https://doi.org/10.1093/oncolo/oyae369 ER -
APA
Zugman, M., McDermott, D. F., Escudier, B. J., Hutson, T. E., Porta, C., Verzoni, E., Atkins, M. B., Rini, B., & Pal, S. K. (2025). Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 study. The Oncologist. https://doi.org/10.1093/oncolo/oyae369
Source records
- crossref · retrieved 2026-09-26T16:09:38.962Z